China Tracker - Details for Biostar Pharmaceuticals (BSPM)

 Biostar Pharmaceuticals
 Yahoo Finance News
2017-02-24BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule
2017-02-09BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
2016-11-26BIOSTAR PHARMACEUTICALS, INC. Financials
2016-11-23BioStar Pharmaceuticals, Inc. :BSPM-US: Earnings Analysis: Q3, 2016 By the Numbers : November 23, 2016
2016-11-21Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended September 30, 2016
2016-11-21Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended September 30, 2016
2016-11-21BIOSTAR PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
2016-11-14Biostar Pharmaceuticals Completes Previously Announced Registered Direct Financing
2016-10-18Biostar Pharmaceuticals Completes Previously Announced Registered Direct Financing
2016-10-12Why Biostar Pharmaceuticals Inc.(BSPM), Telefonaktiebolaget LM Ericsson (ERIC), and Three Other Stocks Are Trading Lower Today
2016-10-12BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events
2016-10-12Biostar Announces Execution of Agreement for $1.91 Million Registered Direct Offering of Shares of Common Stock and Warrants
2016-10-11Biostar Pharma Skyrockets on New Chinese Product Launch
2016-10-11Why Biostar Pharmaceuticals Inc. (BSPM), Nova Lifestyle Inc. (NVFY) & Three Other Stocks Are Trading Higher on Tuesday
2016-10-11Biostar to Launch a New Product Aimed at Treating Effects of Rhinitis and Sinusitis
2016-09-22BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events
2016-09-22Biostar Pharmaceuticals Signs a Letter of Intent to Acquire Xianyang Yongsheng Health Products Co., Ltd.
2016-08-22BIOSTAR PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
2016-08-22Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended June 30, 2016
2016-06-28BioStar Pharmaceuticals, Inc. :BSPM-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016
BSPM
Healthcare & Drugs
SCORE
6
READ: Score Cards Explained
SAFETY/RISK SCORE
EXTREME RISK
DETAILS: Safety/Risk Model for BSPM
Current Price:  $2.23
F10k Day (2009-08-14): -81.42%$12.00
2009 Close: -83.30%$13.35
2010 Close: -73.65%$8.46
2011 Close: 19.89%$1.86
High (2012-04-23): 5.68%$2.11
Low (2012-04-03): 298.21%$0.56
Exchange: NCM
Market Capitalization: 20.96 mill
Total Shares: 9.40 mill
Float: 2,194,000.00 mill
Avg Volume: 153.20 k
Short Interest: 47.90 k
Short Ratio: 0.08%0.3 d
Last Quarter: 2012-06-30
Revenue (MRQ): 8.16 mill
Net Income (MRQ): -1.58 mill
Op. Cash Flow (MRQ): -3.02 mill
all financial data provided without warranty